Why We Measure the Length of Your Child’s Eye

What Axial Length Is

A typical adult eye falls somewhere around 23 to 24.5 millimeters. Newborn eyes are much shorter, around 16 to 17 millimeters, and they lengthen rapidly through infancy before settling into a slow, controlled growth that is normally matched by a compensating flattening of the cornea and lens. Myopia develops when that coordination breaks down and the eye keeps growing past the point its optics can compensate for.

The scale is what makes this counterintuitive. As a rough working rule, one additional millimeter of length is worth something in the region of two and a half to three diopters of myopia. That means a change of a tenth of a millimeter, invisible by any other means, is a clinically meaningful amount of progression. It also means that measuring in quarter-diopter prescription steps is a blunt instrument for the job.

Why the Prescription Is Not Enough

Prescription is not wrong. It is simply the wrong tool for tracking progression, for four specific reasons.

• It is quantized. Prescriptions are written in 0.25 diopter steps. Real change is continuous, so a child can grow measurably for most of a year and still be handed the same prescription, which reads to a parent as "stable."
• It is affected by focusing. Children have powerful accommodation. A tired, anxious, or over-focusing child can measure a quarter or half diopter different from one visit to the next with no change in the eye at all. Biometry is immune to this.
• It bundles two variables. The refraction reflects both the eye’s length and the focusing power of the cornea and lens. Two children with the same prescription can have quite different axial lengths, and the longer eye carries the higher long-term risk.
• It has no reference curve. Nobody can tell you whether minus 2.75 is appropriate for a nine year old. Normative data does exist for axial length by age, so a measurement can be positioned against a population rather than floating on its own.

We record refraction at every visit and we take it seriously, because it is what determines the lens design and what the child actually experiences. For the question of whether progression is being controlled, we look at the biometry. Both numbers appear in your progress report.

How the Measurement Is Taken

Axial length is measured with an optical biometer. The child rests their chin on a support, looks at a small fixation target, and the instrument sends a beam of low-coherence light into the eye and times its reflection from the retina. Nothing touches the eye, no drops are needed, and there is no discomfort or bright flash. The capture itself takes a few seconds per eye.

The instrument takes multiple readings and reports both an average and a measure of scatter, which tells us whether the child held still enough for the result to be trusted. If the scatter is high, we repeat it. A good measurement is repeatable to a small fraction of the change we are looking for, which is what makes annual comparison meaningful.

• No dilation required. Unlike a cycloplegic refraction, biometry does not need drops, so there is no blurry afternoon afterward.
• Same instrument, same conditions. We measure with the same device each time. Mixing instruments introduces offsets that can masquerade as growth or as control.
• Both eyes, every time. Eyes frequently progress at different rates, and an asymmetry that develops over time is itself a finding.
• Corneal curvature captured alongside. Knowing how much of the refraction comes from corneal power and how much from length makes the picture complete.

The instruments we use and why we chose them are described in Technology and Diagnostics. Biometry sits alongside corneal topography in the baseline workup.

Normal Growth Versus Concerning Growth

Every eye grows a little. The question is always whether it is growing more than it should for that child’s age. Growth slows steadily through childhood, so the same rate means different things at different ages.

As a general orientation, sustained growth above roughly 0.2 millimeters per year in a school-age myopic child is the range where we would want an active control plan rather than observation. Growth around or below 0.1 millimeters per year in that age group is the kind of result a control program is aiming for. Between those, we look at trend rather than a single interval.

How We Chart It for You

A number in a chart note helps nobody. Every child in the myopia control program gets a written progress report with the measurement plotted over time, and you get a copy.

1. 1

   Baseline before treatment

   Axial length in both eyes, corneal curvature, refraction, and every past prescription you can supply. This is the line everything else is compared against, so we take it carefully and repeat it if the scatter is high.

2. 2

   An expected-growth line

   We plot what growth would likely look like for a child of that age, sex, and starting profile without intervention. It is a projection rather than a prophecy, and we say so, but it gives the chart a reference to be measured against.

3. 3

   Scheduled remeasurement

   Typically at six months and twelve months in the first year, then annually or semi-annually depending on the picture. Faster progressors are measured more often, not less.

4. 4

   A plain-language read

   Each report says what the interval showed, whether it is in line with the target, and what we recommend doing next. If the honest answer is that it is too early to tell, that is what it says.

5. 5

   A decision point when needed

   If growth is outpacing the target after a fair trial with good wear, we review nightly wear time honestly, check lens centration and treatment zone size against pupil diameter, and discuss combination therapy.

You are welcome to take that report to any other eye care provider, and we encourage it if you want a second opinion. It contains the actual numbers, not a summary. Follow-up scheduling is described in Follow-Up Care and Long-Term Maintenance.

What the Number Cannot Tell You

Being honest about a metric means describing where it stops being useful.

• It cannot prove causation for one child. If your child grows slowly on treatment, we cannot know with certainty they would have grown quickly without it. What we have is their own prior trajectory and population expectations, which together make a strong but not airtight case.
• It does not predict an individual endpoint. Axial length tells you where the eye is and how fast it is moving. It does not tell you the exact prescription your child will have at twenty.
• Short intervals are noisy. A three-month gap is usually too short to distinguish real growth from measurement variation. We generally will not draw conclusions from one.
• It says nothing about lens fit or comfort. Corneal health, centration, and how the child is actually doing are separate assessments at every visit.
• It is not a substitute for a dilated retinal exam. Long eyes need their retinas looked at. Biometry tracks growth. It does not inspect tissue.

Used with those limits in mind, axial length remains the most informative single number in pediatric myopia care, and it is the reason our program can tell you whether it is working rather than asking you to assume. The wider evidence context is in Clinical Evidence, and the mechanism the measurement is tracking is explained in Slowing Progression.